Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis

Genes and Immunity

Volumn 14, Issue 2, 2013, Pages 83-89

  Snir, O ^a   Hesselberg, E ^a   Amoudruz, P ^a   Klareskog, L ^a   Zarea Ganji, I ^a   Catrina, A I ^a   Padyukov, L ^a   Malmstrom V ^a   Seddighzadeh, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 14; LIPOPOLYSACCHARIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SEROTONIN 2 RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; AMPHETAMINES; ARTHRITIS, RHEUMATOID; ENTEROTOXINS; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN RECEPTOR AGONISTS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874762110     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.56     Document Type: Article

References (29)

1. Wright AF. Genomics of common diseases: approaching the tipping point. Genome Med 2011; 3: 70.
2. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
3. Abdouh M, Storring JM, Riad M, Paquette Y, Albert PR, Drobetsky E et al. Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 2001; 276: 4382-4388.
4. Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 2004; 172: 6011-6019.
5. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007; 109: 3139-3146.
6. Matsuda H, Ushio H, Geba GP, Askenase PW. Human platelets can initiate T celldependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol 1997; 158: 2891-2897.
7. O'Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 2006; 107: 1010-1017.
8. Sternberg EM, Trial J, Parker CW. Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol 1986; 137: 276-282.
9. Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 1998; 12: 249-271.
10. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71: 533-554.
11. Cloe? z-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM. Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003; 15: 233-240.
12. Roth BL, Willins DL, Kristiansen K, Kroeze WK. Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther 1998; 79: 231-257.
13. de Clerck F, David JL, Janssen PA. Inhibition of 5-hydroxytryptamine- induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. Agents Actions 1982; 12: 388-397.
14. Roth BL, Berry SA, Kroeze WK, Willins DL, Kristiansen K. Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. Crit Rev Neurobiol 1998; 12: 319-338.
15. Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C et al. Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 2005; 17: 599-606.
16. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 2000; 14: 219-224.
17. Inoue M, Okazaki T, Kitazono T, Mizushima M, Omata M, Ozaki S. Regulation of antigen-specific CTL and Th1 cell activation through 5-Hydroxytryptamine 2A receptor. Int Immunopharmacol 2011; 11: 67-73.
18. Guillet-Deniau I, Burnol AF, Girard J. Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J Biol Chem 1997; 272: 14825-14829.
19. Yu B, Becnel J, Zerfaoui M, Rohatgi R, Boulares AH, Nichols CD. Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factoralpha- induced inflammation with extraordinary potency. J Pharmacol Exp Ther 2008; 327: 316-323.
20. Walterscheid JP, Nghiem DX, Kazimi N, Nutt LK, McConkey DJ, Norval M et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci USA 2006; 103: 17420-17425.
21. Davydova SM, Cheido MA, Gevorgyan MM, Idova GV. Effects of 5-HT2A receptor stimulation and blocking on immune response. Bull Exp Biol Med 2010; 150: 219-221.
22. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-514.
23. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869-871.
24. Seddighzadeh M, Korotkova M, Kallberg H, Ding B, Daha N, Kurreeman FA et al. Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis. Eur J Hum Genet 2010; 18: 821-826.
25. Nelson DL, Lucaites VL, Wainscott DB, Glennon RA. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors. Naunyn Schmiedebergs Arch Pharmacol 1999; 359: 1-6.
26. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev 2008; 108: 1614-1641.
27. Arzt E, Costas M, Finkielman S, Nahmod VE. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci 1991; 48: 2557-2562.
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
29. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.